Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Key Points

• The research aims to explore the role of SUV39H1 as a therapeutic target in treating multiple myeloma.
• Assessment of SUV39H1 expression in multiple myeloma cells
• Evaluation of inhibitors targeting SUV39H1
• Analysis of effects on cell proliferation and survival
• Inhibition of SUV39H1 leads to reduced survival of multiple myeloma cells
• Targeting SUV39H1 demonstrates potential as a novel treatment strategy
• Inhibition affects epigenetic regulation mechanisms involved in cancer progression